> introduction               > shareholder letter               > download financials               > company info
Expanding U.S.realizable markets (total estimated)
Endovascular treatment represents the next frontier for Possis. Through strategic development of value-added, non-AngioJet thrombectomy products that build on our core technologies, we’ll introduce endovascular treatments that serve unmet market needs.